The Regents of the University of California have been awarded US Patent No. 8,778,608, "CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma."
Arie Belldegrun and Allan Pantuck are named as inventors.
Good Start Genetics has been awarded US Patent No. 8,778,609, "Methods for analyzing nucleic acids."